DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 99.65M
Enterprise value 82.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.24
Price/book (mrq)1.25
Enterprise value/revenue 3.11
Enterprise value/EBITDA -1.62

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 3-42.26%
S&P500 52-week change 31.77%
52-week high 37.6900
52-week low 33.1300
50-day moving average 33.7810
200-day moving average 34.5107

Share statistics

Avg vol (3-month) 3162.55k
Avg vol (10-day) 3111.8k
Shares outstanding 526.36M
Implied shares outstanding 6N/A
Float 821.99M
% held by insiders 112.97%
% held by institutions 136.18%
Shares short (14 May 2023) 42.04M
Short ratio (14 May 2023) 411.48
Short % of float (14 May 2023) 48.28%
Short % of shares outstanding (14 May 2023) 47.73%
Shares short (prior month 13 Apr 2023) 41.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Nov 2019
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin -221.66%
Operating margin (ttm)-200.08%

Management effectiveness

Return on assets (ttm)-28.33%
Return on equity (ttm)-63.48%

Income statement

Revenue (ttm)26.66M
Revenue per share (ttm)1.04
Quarterly revenue growth (yoy)-12.30%
Gross profit (ttm)14.01M
EBITDA -48.45M
Net income avi to common (ttm)-57.88M
Diluted EPS (ttm)-2.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.09M
Total cash per share (mrq)1.63
Total debt (mrq)26.37M
Total debt/equity (mrq)36.61
Current ratio (mrq)3.15
Book value per share (mrq)2.78

Cash flow statement

Operating cash flow (ttm)-34.51M
Levered free cash flow (ttm)-15.43M